AGF Management’s Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A BSX.PRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-25,000
Closed -$3.03M 773
2023
Q1
$3.03M Buy
25,000
+10,000
+67% +$1.15M 0.02% 441
2022
Q4
$1.72M Buy
+15,000
New +$1.65M 0.01% 515

Other funds holding BSX.PRA

AGF Management's BSX.PRA Position: Q2 2023 in Review

AGF Management sold out of Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A (BSX.PRA) in Q2 2023, closing a stake of 25,000 shares — an estimated $3.03M sold.

AGF Management first reported a position in BSX.PRA in Q4 2022 and held it in 2 quarters. The position peaked at $3.03M in Q1 2023. 1 fund tracked by Wall St. Rank holds BSX.PRA as of Q2 2023.

  • AGF Management reported no remaining Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A position as of Q2 2023 after selling out during the quarter.
  • AGF Management sold 25,000 Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A shares in Q2 2023, an estimated $3.03M.
  • AGF Management first reported a position in Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A in Q4 2022 and held it in 2 quarters.
  • AGF Management's Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A position peaked at $3.03M in Q1 2023.
  • 1 fund tracked by Wall St. Rank held Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A as of Q2 2023.

Based on AGF Management's 13F filing for Q2 2023, filed 9 Aug 2023.